Skip to main content

Client News

ABIVAX publishes data of ABX464 induction and long-term maintenance phase 2A ulcerative colitis study in the jounal “Gastroenterology”

3rd March 2021

Molecular Health and FALCO biosystems team up to provide genetic analysis services using MH Guide/BRCA and MH Guide/Mendel

2nd March 2021

InflaRx Announces Closing of $75 Million Public Offering of Common Shares and One-Year Warrants

1st March 2021

Abivax appoints Dr Sophie Biguenet, M.D., as Chief Medical Officer

1st March 2021

Marinomed Biotech AG Leads BCG’s Gender Diversity Index Austria 2020

26th February 2021

InflaRx Announces Pricing of $75 Million Public Offering of Common Shares and One-Year Warrants

25th February 2021

DEBx Medical Receives CE Mark and ISO 13485 Certification for Debrichem® for Chemical Debridement

25th February 2021

Marinomed Biotech AG announces positive clinical data for Carragelose lozenges against respiratory viruses including SARS-CoV-2

24th February 2021

RedHill Biopharma Announces Planned Expansion of Opaganib Global Phase 2/3 COVID-19 Study to the U.S.

23rd February 2021

XPhyto builds commercial team to launch 25-minute COVID-19 RT-PCR test

22nd February 2021